Debt Instrument, Fair Value Disclosure
Thermo Fisher Scientific Debt Instrument, Fair Value Disclosure increased by 8.6% to $39.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.4%, from $31.19B to $39.75B. Over 5 years (FY 2020 to FY 2025), Debt Instrument, Fair Value Disclosure shows an upward trend with a 8.2% CAGR.
Analysis
How to read this metric
If the fair value is significantly lower than the carrying amount, it may indicate an opportunity to repurchase debt at a discount or reflect rising market interest rates.
Detailed definition
This represents the estimated fair market value of the company's total debt obligations, which may differ from the carry...
Peer comparison
Publicly traded companies with significant bond issuances are required to disclose this to show the market's current valuation of their credit risk.
other_debt_instrument_fair_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.77B | $23.50B | $36.05B | $32.25B | $27.34B | $25.11B | $30.29B | $31.64B | $30.11B | $30.78B | $32.27B | $32.66B | $32.06B | $33.04B | $28.53B | $31.19B | $32.40B | $33.08B | $36.61B | $39.75B |
| QoQ Change | — | +13.1% | +53.4% | -10.5% | -15.2% | -8.2% | +20.6% | +4.5% | -4.8% | +2.2% | +4.8% | +1.2% | -1.9% | +3.1% | -13.7% | +9.3% | +3.9% | +2.1% | +10.7% | +8.6% |
| YoY Change | — | — | — | — | +31.6% | +6.9% | -16.0% | -1.9% | +10.1% | +22.6% | +6.5% | +3.2% | +6.5% | +7.3% | -11.6% | -4.5% | +1.1% | +0.1% | +28.3% | +27.4% |
Debt Instrument, Fair Value Disclosure at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's debt instrument, fair value disclosure?
- Thermo Fisher Scientific (TMO) reported debt instrument, fair value disclosure of $39.75B in Q1 2026.
- How has Thermo Fisher Scientific's debt instrument, fair value disclosure changed year-over-year?
- Thermo Fisher Scientific's debt instrument, fair value disclosure increased by 27.4% year-over-year, from $31.19B to $39.75B.
- What is the long-term trend for Thermo Fisher Scientific's debt instrument, fair value disclosure?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's debt instrument, fair value disclosure has grown at a 8.2% compound annual growth rate (CAGR), from $24.66B to $36.61B.
- What does debt instrument, fair value disclosure mean?
- The current market price to buy back or pay off the company's debt.